Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin in alveolar ridge augmentation
NCT04971382Phase 4Unknown
- Sponsor
- Ain Shams University
- Start
- Dec 2021
- Primary completion
- Mar 2024
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of curcumin in periodontitis (2 arms), sponsored by Ain Shams University. Primary endpoint: Clinical outcome at 6 months. Status: unknown.
02
Drugs
curcumin
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT04971382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04971382.